Civilization Ventures

Funding rounds backed by Civilization Ventures.

Export CSV
Funding disclosed in full
$89.4M
Median round
$44.7M
Rounds in calculation
2
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Infinimmune

Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease

$75MSeries ABiotechUnited States
11 participantsCivilization VenturesEverbright BiofundForge Life Science PartnersGodfrey CapitalGoldcrest CapitalMerck Global Health Innovation FundPear VCPlayground GlobalRA Capital ManagementRegeneron VenturesWild Tree Ventures
Syntax Bio

Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine

$14.4MSeries A+BiotechUnited States
16 participantsAllegis CapitalAstellas Venture ManagementCivilization VenturesDCVC BioDraper AssociatesEGB CapitalExit FundIllinois VenturesIllumina VenturesLongGameMansueto OfficeMayo ClinicPortal InnovationsSigma Groupthe Illinois Department of Commerce and Economic OpportunityWalder Ventures